- Home
- PTPI vs CERO Comparison
PTPI vs CERO Comparison
Compare PTPI & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTPI
- CERO
- Stock Information
- Founded
- PTPI 2020
- CERO 2017
- Country
- PTPI United States
- CERO United States
- Employees
- PTPI N/A
- CERO N/A
- Industry
- PTPI Biotechnology: Pharmaceutical Preparations
- CERO
- Sector
- PTPI Health Care
- CERO
- Exchange
- PTPI Nasdaq
- CERO Nasdaq
- Market Cap
- PTPI 2.6M
- CERO 3.1M
- IPO Year
- PTPI N/A
- CERO N/A
- Fundamental
- Price
- PTPI $0.04
- CERO $0.62
- Analyst Decision
- PTPI
- CERO
- Analyst Count
- PTPI 0
- CERO 0
- Target Price
- PTPI N/A
- CERO N/A
- AVG Volume (30 Days)
- PTPI 91.2M
- CERO 963.3K
- Earning Date
- PTPI 05-14-2025
- CERO 05-16-2025
- Dividend Yield
- PTPI N/A
- CERO N/A
- EPS Growth
- PTPI N/A
- CERO N/A
- EPS
- PTPI N/A
- CERO N/A
- Revenue
- PTPI $5,112,043.00
- CERO N/A
- Revenue This Year
- PTPI $9.25
- CERO N/A
- Revenue Next Year
- PTPI N/A
- CERO N/A
- P/E Ratio
- PTPI N/A
- CERO N/A
- Revenue Growth
- PTPI N/A
- CERO N/A
- 52 Week Low
- PTPI $0.04
- CERO $0.53
- 52 Week High
- PTPI $0.90
- CERO $172.00
- Technical
- Relative Strength Index (RSI)
- PTPI 34.54
- CERO 30.38
- Support Level
- PTPI $0.06
- CERO $0.53
- Resistance Level
- PTPI $0.11
- CERO $0.84
- Average True Range (ATR)
- PTPI 0.01
- CERO 0.10
- MACD
- PTPI 0.00
- CERO 0.03
- Stochastic Oscillator
- PTPI 1.45
- CERO 23.31
About PTPI Petros Pharmaceuticals Inc.
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.